VERZENIO (abemaciclib) Patient Assistance Program
Don’t let the high cost of brand specialty breast cancer therapy stand between you and the treatment you need. We help eligible patients access Verzenio (abemaciclib) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Verzenio (abemaciclib) is FDA-approved for adults with hormone receptor-positive (HR+), HER2-negative breast cancer — for early-stage, node-positive, high-risk breast cancer (in combination with endocrine therapy as adjuvant treatment), and for advanced or metastatic disease (in combination with an aromatase inhibitor or fulvestrant)
- Without assistance, the retail cost commonly runs approximately $14,000–$18,000 per 30-day supply at standard maintenance doses.
- Through AffordMyPrescriptions, qualifying patients can access Verzenio for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
- There is no generic version of Verzenio available in the U.S. as of 2026
What is Verzenio Prescription Assistance Program?
The Verzenio Prescription Assistance Program is a manufacturer-sponsored initiative that provides Verzenio at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for breast cancer patients who are uninsured or underinsured, as well as Medicare Part D beneficiaries.
Navigating the program on your own means dealing with eligibility verification, oncology-team coordination, prior-authorization documentation, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and annual re-certification — so you focus on your treatment, not paperwork.
Pharmacy Price Comparison
- Without assistance, Verzenio costs roughly $14,000–$18,000 per 30-day supply at retail pharmacies. Discount coupons offer little relief at this price level. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$17,500.00 | Save ~$17,430/mo |
| CVS Pharmacy | ~$18,000.00 | Save ~$17,930/mo |
| Walmart | ~$15,800.0 | Save ~$15,730/mo |
| Costco | ~$15,200.00 | Save ~$15,130/mo |
| Specialty Pharmacy | ~$15,000.00 | Save ~$14,930/mo |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. Afford My Prescriptions Advocacy Service bypasses retail pricing by using drug manufacturer programs to secure your medication for you—independent of dosage or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Verzenio Prescription Program?
The Patient Assistance Program is free to apply for and provides Verzenio at no medication cost if approved. But the process involves detailed applications, oncology-team coordination, prior-authorization documentation, and ongoing renewal management. Our $69.95/month service covers full advocacy: applications, doctor coordination, documentation, refill management, and annual re-enrollment — so you focus on your treatment, not paperwork.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Verzenio:
Limitations of Coupons
Prices fluctuate — savings aren’t guaranteed month-to-month
Copay accumulators may prevent savings from counting toward your deductible
Coupon cards expire and require constant renewal
Still $14,000–$18,000 per month even with the best discount
Cannot be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
Medication supplied directly through the assistance program
We manage all paperwork, refills, and annual renewals
Medicare Part D patients accepted
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Verzenio assistance.Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Verzenio assistance.
- You are a U.S. citizen or legal resident
- You Have A Valid Verzenio Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Understanding Verzenio:
Verzenio (abemaciclib) is an oral, targeted oncology medicine in the CDK4/6 inhibitor class used to treat hormone receptor-positive (HR+), HER2-negative breast cancer. It is approved for adjuvant treatment of early-stage, node-positive, high-risk breast cancer (in combination with endocrine therapy) and for advanced or metastatic HR+/HER2- breast cancer in combination with an aromatase inhibitor or fulvestrant.
How It Works:
Verzenio is a CDK4/6 inhibitor designed to treat hormone receptor-positive breast cancers by blocking enzymes that drive cell division. By stopping the cancer cells at a specific checkpoint (transitioning from G1 to S phase), it effectively halts the rapid growth of the tumor. When used with endocrine therapy, it creates a dual blockade that attacks the cancer’s growth signals from two different directions.
Form and Use:
The medication is taken by mouth twice daily, either with or without food, on a continuous schedule with no “off” days. Starting doses range from 150 mg to 200 mg depending on whether it is being used alone or in combination with other treatments. Your oncology team will monitor your progress and may adjust the dosage if you experience side effects like diarrhea or changes in blood counts.
Generic Availability:
As of 2026, there is no FDA-approved generic version of Verzenio available in the U.S. due to active patent and exclusivity protections. While other similar CDK4/6 inhibitors like palbociclib and ribociclib are approved for the same type of breast cancer, they are not direct generic substitutes. The choice of which inhibitor is a clinical fit depends on your specific indication and side-effect profile as determined by your oncology team.
Warnings:
Diarrhea is the most common side effect and typically requires active management, such as the use of loperamide, especially during the first few weeks of therapy. Other serious risks include low white blood cell counts, lung inflammation, liver toxicity, and the formation of blood clots. Standard care involves regular blood counts and liver-function testing to ensure the treatment is being tolerated safely.
FAQ (Frequently Asked Questions)
How Much Does Verzenio Cost Without Insurance?
The retail price commonly runs $14,000–$18,000 per 30-day supply at standard maintenance doses. Coupon discounts at major pharmacies exist but are modest because the underlying price is so high. Through AffordMyPrescriptions, qualifying patients receive Verzenio at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
How Is Verzenio Taken?
Verzenio is taken by mouth twice daily, with or without food. Take it at roughly the same times each day. The starting dose is 150 mg twice daily in combination with endocrine therapy, or 200 mg twice daily as monotherapy. Your oncology team will adjust dosing as needed for diarrhea or other side effects.
Are There Other CDK4/6 Inhibitors I Should Know About?
Yes. Palbociclib and ribociclib are also FDA-approved CDK4/6 inhibitors for HR+/HER2- breast cancer. Whether any of these is a better clinical fit than Verzenio depends on the indication, side-effect profile, dosing schedule, and other factors. We mention this directly because if a different therapy on a more accessible assistance pathway would work for your situation, that may be a better path.
Can I Get Verzenio Through The PAP If I Have Medicare?
Yes. Medicare Part D beneficiaries can typically qualify for Verzenio Patient Assistance, especially if you face specialty-tier copays you cannot afford. The manufacturer’s commercial copay savings program is reserved for commercially insured patients only — but the underlying PAP supports Medicare patients who meet income criteria.
What Should I Expect With Diarrhea?
Diarrhea is the most common side effect of Verzenio, occurring in the majority of patients and most often in the first weeks of treatment. Your oncology team will give you specific guidance on managing it, including when to start over-the-counter loperamide and when to call. With prompt management, most diarrhea episodes are mild to moderate and don’t require dose changes.
How Long Does It Take To Get Approved?
If your initial application is denied, we explore alternative savings paths on your behalf — including independent oncology-focused foundations such as the PAN Foundation or HealthWell Foundation, breast-cancer-specific organizations like Susan G. Komen or Living Beyond Breast Cancer, the manufacturer’s copay savings program if you have commercial insurance, or asking your oncology team whether a different CDK4/6 inhibitor would be appropriate. If we cannot find a path, you will not be charged our service fee.
Take Control of Your Medication Costs
If you are struggling with the high cost of Verzenio, our team may be able to help you access assistance programs designed to make brand specialty breast cancer therapy affordable. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.